Evidence of worse survival has been reported in IDHm astrocytoma WHO grade 4 with diagnosis based upon CDKN2A/B deletion only compared to IDHm astrocytoma WHO grade 4 where diagnosis has been based upon morphology [8, 11]. This evidence concerns the gene CDKN2A and astrocytoma (excluding glioblastoma).